메뉴 건너뛰기




Volumn 69, Issue 4, 1996, Pages 335-339

Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patients

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TAMOXIFEN;

EID: 0029821812     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960822)69:4<335::AID-IJC17>3.3.CO;2-W     Document Type: Article
Times cited : (53)

References (21)
  • 1
    • 0028211185 scopus 로고
    • In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells
    • BLAT, C., VILLAUDY, J. and BINOUX, M., In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J. clin. Invest., 93, 2286-2290 (1994).
    • (1994) J. Clin. Invest. , vol.93 , pp. 2286-2290
    • Blat, C.1    Villaudy, J.2    Binoux, M.3
  • 2
    • 0024539364 scopus 로고
    • Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer
    • COLLETTI, R.B., ROBERTS, J.D., DEVLIN, J.T. and COPELAND, K.C., Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer. Cancer Res., 49, 1882-1884 (1989).
    • (1989) Cancer Res. , vol.49 , pp. 1882-1884
    • Colletti, R.B.1    Roberts, J.D.2    Devlin, J.T.3    Copeland, K.C.4
  • 4
    • 0027292076 scopus 로고
    • Two site- Specific radioimmunoassays which demonstrate the presence of proteolytically modified insulin-like growth factor-binding protein-3 in circulation
    • CWYFAN-HUGHES, S.C., WASS. J.A.H. and HOLLY, J.M.P., Two site- specific radioimmunoassays which demonstrate the presence of proteolytically modified insulin-like growth factor-binding protein-3 in circulation. J. Endocrinol., 137, 321-328 (1993).
    • (1993) J. Endocrinol. , vol.137 , pp. 321-328
    • Cwyfan-Hughes, S.C.1    Wass, J.A.H.2    Holly, J.M.P.3
  • 6
    • 0029938078 scopus 로고    scopus 로고
    • Effects of treatment with megestrol acetate, aminoglutethimide or formestane on insulin-like growth factor (IGF)-I and -II, IGF-binding proteins and IGFBP-3 protease status in patients with advanced breast cancer
    • FROST, V.J., HELLE, S.I., LØNNING, P.E., VAN DER STAPPEN, J.W.J. and HOLLY, J.M.P., Effects of treatment with megestrol acetate, aminoglutethimide or formestane on insulin-like growth factor (IGF)-I and -II, IGF-binding proteins and IGFBP-3 protease status in patients with advanced breast cancer. J. clin. endocrinol. Metab., 81, 2216-2221 (1996).
    • (1996) J. Clin. Endocrinol. Metab. , vol.81 , pp. 2216-2221
    • Frost, V.J.1    Helle, S.I.2    LØnning, P.E.3    Van der Stappen, J.W.J.4    Holly, J.M.P.5
  • 7
    • 0029124925 scopus 로고
    • Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin dependent diabetic patients compared to that in healthy subjects
    • HILDING, A., BRISMAR, K., DEGERBLAD, M., THOREN, M. and HALL, K., Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin dependent diabetic patients compared to that in healthy subjects. J. clin. endocrinol. Metab., 80, 2646-2652 (1995).
    • (1995) J. Clin. Endocrinol. Metab. , vol.80 , pp. 2646-2652
    • Hilding, A.1    Brismar, K.2    Degerblad, M.3    Thoren, M.4    Hall, K.5
  • 9
    • 0025074841 scopus 로고
    • Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy
    • HOSSENLOPP, P., SEGOVIA, B., LASSARRE, C., ROOHANI, M., BREDON, M. and BINOUX, M., Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J clin. endocrinol Metab., 71, 797-805 (1990).
    • (1990) J Clin. Endocrinol Metab. , vol.71 , pp. 797-805
    • Hossenlopp, P.1    Segovia, B.2    Lassarre, C.3    Roohani, M.4    Bredon, M.5    Binoux, M.6
  • 10
    • 0027174116 scopus 로고
    • In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen
    • HUYNH, H.T., TETENES, E., WALLACE, L. and POLLAK, M., In vivo inhibition of insulin-like growth factor I gene expression by tamoxifen. Cancer Res., 53, 1727-1730 (1993).
    • (1993) Cancer Res. , vol.53 , pp. 1727-1730
    • Huynh, H.T.1    Tetenes, E.2    Wallace, L.3    Pollak, M.4
  • 11
    • 0028958031 scopus 로고
    • Insulin-like growth factors and their binding proteins: Biological actions
    • JONES, J.I. and CLEMMONS, D.R., Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev., 16, 3-34 (1995).
    • (1995) Endocrine Rev. , vol.16 , pp. 3-34
    • Jones, J.I.1    Clemmons, D.R.2
  • 12
    • 0023710584 scopus 로고
    • Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol
    • KAREY, K.P. and SIRBASKU, D.A., Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol. Cancer Res., 48, 4083-4092 (1988).
    • (1988) Cancer Res. , vol.48 , pp. 4083-4092
    • Karey, K.P.1    Sirbasku, D.A.2
  • 13
    • 0028342709 scopus 로고
    • Plasma insulin-like growth factor I and its binding protein I and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen
    • LAHTI, E.I., KNIP, M. and LAATIKAINEN, T.J., Plasma insulin-like growth factor I and its binding protein I and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen. Cancer, 74, 618-624 (1994).
    • (1994) Cancer , vol.74 , pp. 618-624
    • Lahti, E.I.1    Knip, M.2    Laatikainen, T.J.3
  • 14
    • 0028354529 scopus 로고
    • Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma
    • LASSARRE, C. and BINOUX, M., Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Endocrinology, 134, 1254-1262 (1994).
    • (1994) Endocrinology , vol.134 , pp. 1254-1262
    • Lassarre, C.1    Binoux, M.2
  • 15
    • 0026779758 scopus 로고
    • Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein 1 in breast cancer patients
    • LØNNING, P.E., HAU., K., AAKVAAG, A. and LIEN, E.A., Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein 1 in breast cancer patients. Cancer Res., 52, 4719-4723 (1992a).
    • (1992) Cancer Res. , vol.52 , pp. 4719-4723
    • LØnning, P.E.1    Hau, K.2    Aakvaag, A.3    Lien, E.A.4
  • 16
    • 0026585136 scopus 로고
    • Clinical pharmacokinetics of endocrine agents used in advanced breast cancer
    • LØNNING, P.E., LIEN, E.A., LUNDGREN, S. and KVINNSLAND, S., Clinical pharmacokinetics of endocrine agents used in advanced breast cancer. Clin. Pharmacokinet., 22, 327-358 (19926).
    • (1992) Clin. Pharmacokinet. , vol.22 , pp. 327-358
    • LØnning, P.E.1    Lien, E.A.2    Lundgren, S.3    Kvinnsland, S.4
  • 18
    • 0026806159 scopus 로고
    • The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer
    • REED, M.J., CHRISTODOULIDES, A., KOISTINEN, R., SÄPPELÄ, M., TEALE, J.D. and GHILCHIK, M.W., The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer. Int. J. Cancer, 52, 208-212 (1992).
    • (1992) Int. J. Cancer , vol.52 , pp. 208-212
    • Reed, M.J.1    Christodoulides, A.2    Koistinen, R.3    Säppelä, M.4    Teale, J.D.5    Ghilchik, M.W.6
  • 19
    • 0028604497 scopus 로고
    • Immunoreactive proinsulin-like growth factor-II in healthy subjects, patients with growth hormone deficiency, and patients with type 1 diabetes: Effects of insulin-like growth factor-I and insulin
    • TALLY, M., ERIKSSON, U., THORÉN, M., BRISMAR, K. and HALL, K., Immunoreactive proinsulin-like growth factor-II in healthy subjects, patients with growth hormone deficiency, and patients with type 1 diabetes: effects of insulin-like growth factor-I and insulin. J. clin. endocrinol. Metab., 79, 1576-1581 (1994).
    • (1994) J. Clin. Endocrinol. Metab. , vol.79 , pp. 1576-1581
    • Tally, M.1    Eriksson, U.2    Thorén, M.3    Brismar, K.4    Hall, K.5
  • 20
    • 0026728537 scopus 로고
    • Tamoxifen attenuates pulsatile growth hormone secretion: Mediation in part by somatostatin
    • TANNENBAUM, G.S., GURD, W., LAPOINTE, M. and POLLAK, M., Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin. Endocrinology, 130, 3395-3401 (1992).
    • (1992) Endocrinology , vol.130 , pp. 3395-3401
    • Tannenbaum, G.S.1    Gurd, W.2    Lapointe, M.3    Pollak, M.4
  • 21
    • 0027104634 scopus 로고
    • Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?
    • ZAPF, J., FUTO, E., PETER, M. and FROESCH, E.R., Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J. clin. Invest., 90, 2574-2584 (1992).
    • (1992) J. Clin. Invest. , vol.90 , pp. 2574-2584
    • Zapf, J.1    Futo, E.2    Peter, M.3    Froesch, E.R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.